Exorna Bioscience
Clinical trials sponsored by Exorna Bioscience, explained in plain language.
-
New Huntington's drug shows promise in small safety trial
Disease control CompletedThis early-phase study tested a new drug called ER2001 in 8 adults with early Huntington's disease. The main goal was to check if the drug is safe and tolerable when given repeatedly through an IV. Researchers also looked at how the drug moves through the body and if it shows any…
Phase: EARLY_PHASE1 • Sponsor: ExoRNA Bioscience • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New Huntington's drug shows promise in early safety trial
Disease control CompletedThis early phase 1 trial tested an experimental drug called ER2001 in 10 adults with early Huntington's disease. The drug was given by IV at increasing doses over 14 weeks to check safety and how the body processes it. The study also looked for early signs that the drug might aff…
Phase: EARLY_PHASE1 • Sponsor: ExoRNA Bioscience • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC